Related Experiment Video
Updated: Jun 10, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Merkel cell carcinoma: clinical characteristics, markers, staging and treatment
Mary H Lien1, Brooke T Baldwin, Sumeet K Thareja
1Department of Dermatology, University of South Florida College of Medicine, Tampa, FL 33612, USA. mlien@health.usf.edu
Abstract:
Merkel cell carcinoma (MCC) is a highly aggressive neoplasm affecting primarily the elderly Caucasian population. Earlier detection of this neoplasm may achieve a better prognosis and an improved outcome. Here, the authors review the typical clinical features of MCC to serve as a reference tool for clinicians in determining when a biopsy may be warranted. An array of immunohistochemical markers may be utilized to differentiate MCC from other neuroendocrine tumors. The staging and concomitant treatment options of MCC are discussed. In addition, the authors review therapeutic advances for treatment of MCC utilizing an array of target proteins.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mitogens and the Cell Cycle
